| Patents for C07D 333 - Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom (32,883) |
|---|
| 10/29/2008 | EP1984321A1 Methods for preparing sulfonamide substituted alcohols and intermediates thereof |
| 10/29/2008 | EP1660474B1 Substituted thiophenes and uses thereof |
| 10/29/2008 | EP1419138B1 N- (1-dimethylaminocycloalkyl)methyl benzamide derivatives |
| 10/29/2008 | EP1216228B1 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 10/29/2008 | CN101296919A Benzo b thiophen derivative and process for production thereof |
| 10/29/2008 | CN101296918A Process for the preparation of duloxetine |
| 10/29/2008 | CN101296901A HIV-1 protease inhibitors, and methods of making and using them |
| 10/29/2008 | CN101296892A PPAR active compounds |
| 10/29/2008 | CN101293890A Novel synthesizing method for dorzolamide HCL midbody |
| 10/29/2008 | CN101293861A Method for preparing aryl sulfone derivatives |
| 10/29/2008 | CN101293799A Method for preparing aldehyde or ketone compounds with catalytic oxidation of alcohol compounds |
| 10/29/2008 | CN100429213C Synthetic method of 2-bromine-3-methylthiophene |
| 10/28/2008 | USRE40558 Peroxisome proliferator-activated receptors agonists/ antagonists; 2-methyl-6-[3-(quinolin-2-ylmethoxy)-propoxymethyl]-benzoic acid; eating diorders; physiological detrimental blood level of insulin, glucose, free fatty acids, or triglycerides; hyperlipemia; atherosclerosis; antidiabetic agent |
| 10/28/2008 | US7442833 e.g. (2E)-3-(4-{(1Z)-2-phenyl-1-[4-(propionyloxy)phenyl]but-1-enyl}phenyl)prop-2-enoic acid; postmenopausal disorders, depressive symptoms; acylating anisole with 2-phenylbutanoic acid followed by demethylation, dehydration to yield phenol aldehyde, acylation and carboxylation to yield ester prodrug |
| 10/28/2008 | US7442702 Prostaglandin agonists |
| 10/28/2008 | CA2300319C 4-cyano-4-deformylsordaricin derivatives |
| 10/23/2008 | WO2008126772A1 Therapeutic agent for hypertension |
| 10/23/2008 | WO2008126731A1 Aryl derivatives |
| 10/23/2008 | WO2008087366A3 Substituted 3-phenyl-1-(phenylthienyl)propan-1-one and 3-phenyl-1-(phenylfuranyl)propan-1-one derivatives, and preparation and use of same |
| 10/23/2008 | US20080262247 Using 3-hydroxy-3(2-thiophenyl)-N-methylpropionamide; chemical intermediate for fluoxetine |
| 10/23/2008 | US20080261994 4-[5-((1S,2R)-1-Carboxy-2-phenyl-cyclopropylsulfamoyl)-thiophen-2-yl]-3,6-dihydro-2H-pyridine-1-carboxylic acid tert-butyl ester; aggrecanase and matrix metalloproteinase (with zinc in the catalytic active center) inhibitor; antiarthritic agent: osteoarthritis, rheumatoid arthritis |
| 10/23/2008 | US20080260669 Aromachemicals |
| 10/22/2008 | EP1982976A1 Process for the manufacture of non-steroidal anti-inflammatory agents and intermediates thereof |
| 10/22/2008 | EP1981866A1 Fungicide n-cycloalkyl-benzyl-amide derivatives |
| 10/22/2008 | CN101291916A 9-aminocarbonylsubstituted derivatives of glycylcyclines |
| 10/22/2008 | CN101289408A Non-steroid progestogen receptor regulator, preparation thereof, pharmaceutical compositions and uses |
| 10/22/2008 | CN100427479C Photochromic perfluoro cyclopentene diaryl ethylene schiff base compound, and its preparing method and use |
| 10/22/2008 | CN100427478C Mulit-wavelength optical storage medium and its preparation method and special production raw material |
| 10/22/2008 | CN100427472C Aryl-heteroaromatic products, compositions containing same and use thereof |
| 10/21/2008 | US7439535 Process for exchanging functional groups by halogen-metal exchange reaction |
| 10/21/2008 | US7439393 Phenethanolamine derivatives for treatment of respiratory diseases |
| 10/21/2008 | US7439372 Therapeutic compounds |
| 10/21/2008 | US7439368 Process for producing 3-acylaminobenzofuran-2-carboxylic acid derivative |
| 10/21/2008 | CA2146707C Substituted n-heteroaroylguanidines as inhibitors of na+/h+ exchange |
| 10/16/2008 | WO2008123349A1 Method for producing n-phenyl-n'-phenylsulfonylpiperazine derivative |
| 10/16/2008 | WO2008123207A1 Ornithine derivative |
| 10/16/2008 | WO2008024302A3 Compounds for treating proliferative disorders |
| 10/16/2008 | US20080255227 7-[(1R,3R,6R,7R)-3-(1,1-difluoropentyl)-3-hydroxy-2-oxabicyclo[4.3.0]nonane-8-one-7-yl]heptanoic acid and a glyceride; improved stability |
| 10/16/2008 | US20080255221 Novel hydroxamates as therapeutic agents |
| 10/16/2008 | US20080255214 Novel hydroxamates as therapeutic agents |
| 10/16/2008 | US20080255206 Rxr Agonists and Antagonists, Alone or in Combination with Ppar Ligands, in the Treatment of Metabolic and Cardiovascular Diseases |
| 10/16/2008 | US20080255198 Biaryloxymethylarenecarboxylic acids as glycogen synthase activator |
| 10/16/2008 | US20080255182 Certain chemical entities, compositions, and methods |
| 10/16/2008 | US20080255169 4'-Fluoro-biphenyl-3-sulfonic acid benzo[1,3]dioxol-5-ylamide, for example; for use as an alpha 2 beta 1 integrin I domain inhibitor; use as a medicament for treating thrombosis and cancer spread |
| 10/16/2008 | US20080255154 Cycloalkylcarbonyl-3H-spiro[2-benzofuran-1,3'-pyrrolidin]-3-ones: N-methyl-5-[4-(1-{[3-oxo-1'H,3H-spiro[2-benzofuran-1,3'-pyrrolidin]-1'-yl]carbonyl}cyclopropyl)phenyl]pyridine-2-carboxamide; 11- beta hydroxyl steroid dehydrogenase type 1 inhibitors; mineralcorticoid receptor antagonists; diabetes |
| 10/16/2008 | US20080255152 Diaryl ethers as opioid receptor antagonists |
| 10/16/2008 | US20080255144 (3'-Chloro-4-methanesulfonyl-biphenyl-2-yl)-[4-(3,4-dichloro-phenyl)-piperazin-1-yl]-methanone; neurological and neuropsychiatric disorders including schizophrenia |
| 10/16/2008 | US20080255126 Inhibitors of post-proline cleaving proteases |
| 10/16/2008 | US20080255108 Novel thiophene sulfoximines, compositions thereof, and methods of treating complement-mediated diseases and conditions |
| 10/16/2008 | US20080255095 Benzylamine analogues |
| 10/16/2008 | CA2681861A1 Ornithine derivative |
| 10/15/2008 | EP1980560A2 C-glycoside derivatives for the treatment of diabetes |
| 10/15/2008 | EP1979322A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 10/15/2008 | EP1979311A2 Phenoxy acetic acids as ppar delta activators |
| 10/15/2008 | EP1692124B1 Biaryl sulfonamides as mmp inhibitors |
| 10/15/2008 | EP1476423B1 Arylsulfonamidobenzylic compounds |
| 10/15/2008 | EP1436300B1 Method for producing, via organometallic compounds, organic intermediate products |
| 10/15/2008 | EP1308436B1 Calcium receptor antagonists |
| 10/15/2008 | EP1142872B1 Aromatic heterocycle compounds having hiv integrase inhibiting activities |
| 10/15/2008 | EP0923544B1 Method for the synthesis of amines and amino acids with organoboron derivatives |
| 10/15/2008 | CN101284826A Process for decolorizing sulfolane |
| 10/15/2008 | CN101284755A Chemical synthesis process for conjugated alkenes compounds |
| 10/15/2008 | CN100425606C Reclamation method of sulfolane containing inorganic salt |
| 10/14/2008 | US7435843 Thiobenzoic acid, N-malonylhydrazide in which the free carboxy group is protected; enhances the desirable tumor attacking properties of anticancer agents without further increasing undesirable side-effects |
| 10/14/2008 | US7435835 Method for producing enantiomer-pure aminoalcohols |
| 10/14/2008 | US7435834 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 10/14/2008 | US7435563 Method for the production of (s)-3-methylamino-1-(thien-2-yl)propan-1-ol |
| 10/14/2008 | CA2309328C Cyclic amine derivatives and their use as drugs |
| 10/09/2008 | WO2008121592A2 Acetyl coenzyme a carboxylase inhibitors |
| 10/09/2008 | WO2008120093A1 Sulfonamides and pharmaceutical compositions thereof |
| 10/09/2008 | WO2008119248A1 Photochemical reaction preparative method of four-membered ring compounds |
| 10/09/2008 | WO2008024304A3 Compounds for treatment of proliferative disorders |
| 10/09/2008 | WO2007120575A3 Niacin receptor agonists, compositions containing such compounds and methods of treatment |
| 10/09/2008 | US20080249139 N-((1S,2R)-1-(3,5-difluorobenzyl)-3-{[(1S)-7-ethyl-1,2,3,4-tetrahydronaphthalen-1-yl]amino}-2-hydroxypropyl)pyrazine-2-carboxamide for example; or corresponding sulfonamides; beta-secretase inhibitors; dementia; Alzheimer's disease |
| 10/09/2008 | US20080249107 Comprising trihydroxy phenyl subunits; selectin inhibitors; side effect reduction; 3-{3-[3-(3,4,5-Trihydroxy-phenyl)-propionylamino]-phenylamino}-benzoic acid |
| 10/09/2008 | US20080249093 immunosuppressive, anti-inflammatory and hemostatic agents to modulate leukocyte trafficking, sequestering lymphocytes in secondary lymphoid tissues, and enhancing vascular integrity; safer and more effective; 3-(4-(5-(3-Cyano-4-isopropyloxyphenyl)-1,2,4-oxadiazol-3-yl)-3-methylphenyl)propanoic acid |
| 10/09/2008 | US20080249071 inhibitory activity against the activation of inflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8 and tumor necrosis factor (TNF- alpha ), NF- kappa K B; inflammatory disorders, autoimmune diseases; side effects reduction; immuno suressants; N-[3,5-bis(trifluoromethyl)phenyl]-2-hydroxybenzamide |
| 10/09/2008 | US20080248422 Resist composition, method of forming resist pattern, compound and acid generator |
| 10/08/2008 | EP1976846A2 Process for preparing duloxetine and intermediates thereof |
| 10/08/2008 | EP1976845A2 A process for the preparation of (s)-(+)-n,n-dimethyl-3-(1-naphthalenyloxy)-3-(2-thienyl)propanamine, a duloxetine intermediate |
| 10/08/2008 | EP1976844A2 Improved process for pure duloxetine hydrochloride |
| 10/08/2008 | EP1976512A1 Novel thiophene derivatives as s1p1/edg1 receptor agonists |
| 10/08/2008 | EP1976511A2 Fluorinated arylamide derivatives |
| 10/08/2008 | EP1539693B9 Cannabinoid receptor agonists |
| 10/08/2008 | EP1456737A4 System and method for displaying editorial content through television navigation controls and electronic program guides |
| 10/08/2008 | EP1335902B1 Heteroarylacryloylaminoalkyl-substituted benzenesulfonamide derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 10/08/2008 | EP1043995B9 INHIBITION OF p38 KINASE ACTIVITY USING ARYL AND HETEROARYL SUBSTITUTED HETEROCYCLIC UREAS |
| 10/08/2008 | CN101282959A Thiophene compound having sulfonyl group and process for producing the same |
| 10/08/2008 | CN101282957A 新的药物化合物 New pharmaceutical compounds |
| 10/08/2008 | CN101282933A Novel NK1 and NK2 antagonists |
| 10/08/2008 | CN101282928A Bicyclo[2.2.1]hept-7-ylamine derivatives and their uses |
| 10/08/2008 | CN101280198A Processing method for waste pollutant in thiophen productioní¬sulphur-containing tar |
| 10/08/2008 | CN101279969A Organic electroluminescent material and application thereof |
| 10/08/2008 | CN101279927A Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
| 10/07/2008 | US7432392 Ester derivatives and medical use thereof |
| 10/07/2008 | US7432389 Inhibiting beta-secretase enzyme activity and A beta peptide production, to reduce amyloid beta deposits or plaques |
| 10/07/2008 | US7432302 Treating proliferative cutaneous disease using a polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; e.g. lupus; use with other biosynthesis enzyme inhibitors |
| 10/07/2008 | US7432289 5-Acylamino-1,1′-biphenyl-4-carboxamide derivatives and their use as P38 kinase inhibitors |
| 10/07/2008 | US7432281 4-(2,2-dichloro)-N-(quinolin-3-yl)benzamide; (1R,2R)2-methyl-N-(quinolin-3-yl)-4-(2-(trifluoromethyl)cyclopropyl)benzamide; inflammation-related conditions in mammals, arthritis, Parkinson's/Alzheimer's diseases, stroke, asthma; acute/chronic or neuropathic pain; VR1 agonist/antagonist |
| 10/07/2008 | US7432264 Antibacterial compounds such as (S)-2-cyano-1-(trans-4-(5-nitro-2-pyridylamino)cyclohexylamino )acetylpyrrolidine; activity against Gram-negative and Gram-positive pathogens, including a methicillin-resistant S. aureus strain |